Why the study?
Does systemically administered nitroglycerin modify alpha-adrenergic receptor agonist-mediated constriction of peripheral veins in healthy male volunteers?
Does systemically administered nitroglycerin modify alpha-adrenergic receptor agonist-mediated constriction of peripheral veins in healthy male volunteers?
Transdermal nitroglycerin does not appear to induce tolerance in peripheral veins, likely due to low plasma concentrations, and high doses do not modify phenylephrine-mediated venoconstriction.
Answers are grounded in this paper and cite their sources.
Transdermal NTG should not change practice in venous tone management; leaves open differential nitrate effects by route in patients.
Nitroglycerin (NTG) is a potent vascular smooth muscle relaxant. With the widespread use of transdermal NTG patches for the prophylaxis of angina, two important issues have arisen: (a) the relative efficacy of transdermal NTG patches compared to other formulations of NTG, and (b) the possibility of development of tolerance to transdermal NTG. We have investigated these two issues by studying the effect of systemically administered NTG (transdermal patches, ointment, and sublingual tablets) on alpha-adrenergic receptor agonist-mediated constriction of human dorsal hand veins. Nitroglycerin patches and ointment (15-60 mg/24 h) applied for 1-4 h did not modify the sensitivity (ED50) to the alpha-adrenergic agonist, phenylephrine. However, sublingual NTG (0.15-0.60 mg) administration caused significant relaxation of partially constricted veins. Following exposure for 24 h to a NTG patch (15 mg/24 h), NTG dose-response curves were not altered suggesting there was no development of tolerance to transdermal NTG. We conclude from our observations that tolerance to transdermal NTG does not appear in veins, possibly due to the low plasma NTG concentrations produced by this preparation. Our results also indicate that high doses of transdermal NTG do not modify phenylephrine-mediated constriction of peripheral veins in humans.
No takes yet. Share an insight, caveat, or question.
Hiremath et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: